Table 2.
Genotype, serotype and NT titer against FCoV from FIP cats
| Case |
Genotype
a
|
Serotype (IFA titer) | NT titer b | |
|---|---|---|---|---|
| Typing I (specimen) | Typing II (specimen) | |||
| FIP-1 |
As |
|
I (400) |
≤10 |
| FIP-2 |
As |
|
I (800) |
10 |
| FIP-3 |
As |
|
I (800) |
≤10 |
| FIP-4 |
As |
|
I (800) |
|
| FIP-5 |
B, R |
|
I (≥1600) |
|
| FIP-6 |
Lu |
|
I (400) |
|
| FIP-7 |
B, R |
|
I (800) |
≤10 |
| FIP-8 |
R |
|
I (800) |
|
| FIP-9 |
B |
|
I (800) |
|
| FIP-10 |
R |
|
I (400) |
|
| FIP-11 |
Pl |
|
I (400) |
10 |
| FIP-12 |
R, Br |
|
I (800) |
≤10 |
| FIP-13 |
R |
|
I (400) |
10 |
| FIP-14 |
Lu |
|
I (400) |
|
| FIP-15 |
As |
|
I (≥1600) |
≤10 |
| FIP-16 |
As |
|
I (200) |
|
| FIP-17 |
As |
|
I (400) |
10 |
| FIP-18 |
R |
|
I (400)/II (400) |
|
| FIP-19 |
As, R |
|
I (400)/II (400) |
|
| FIP-20 |
As |
|
I (≥1600)/II (400) |
|
| FIP-21 |
|
As, B, R |
II (≥1600) |
|
| FIP-22 |
|
Br |
II (≥1600) |
400 |
| FIP-23 |
|
Pl, Li, Ki |
II (≥1600) |
≥1600 |
| FIP-24 |
|
As, CSF, Ki |
I (≥1600)/II (≥1600) |
800 |
| FIP-25 |
|
|
I (≥1600) |
10 |
| FIP-26 |
|
|
I (400) |
≤10 |
| FIP-27 |
|
|
I (400) |
10 |
| FIP-28 |
|
|
I (800) |
≤10 |
| FIP-29 |
|
|
I (200)/II (400) |
≥1600 |
| FIP-30 |
|
|
I (800)/II (≥1600) |
≥1600 |
| FIP-31 |
|
|
I (400) |
≤10 |
| FIP-32 |
|
|
I (400) |
≤10 |
| FIP-33 |
|
|
I (800) |
≤10 |
| FIP-34 |
|
|
I (≥1600) |
10 |
| FIP-35 |
|
|
I (800) |
≤10 |
| FIP-36 | I (400) | ≤10 | ||
a: R, Rectal swabs; As, Ascites; Pl, Pleural effusions; B, Blood; CSF, Cerebrospinal fluid; Li, Liver; Lu, Lung; Ki, Kidney; Br, Brain.
b: NT titer against a type II FIPV.